Beyond Alternatives Company of TAAT® to Launch “Jayvees” Brand at CHAMPS Las Vegas Trade Show
- Wall St rises as traders assess jobs data; consumer sentiment improves
- U.S. economy adds 199,000 jobs in November
- Fed should 'lowball' rate cuts expectations next week says analyst after strong jobs data
- Bernstein's best idea for 2024? Short Tesla stock
- Analysts defend Broadcom as annual guidance falls short after FQ4 earnings beat
Beyond Alternatives’ inaugural brand “Jayvees” will be launched at the CHAMPS Las Vegas trade show starting on Wednesday, February 8, 2023, featuring an initial selection of combustible and edible products made using novel cannabinoids. Jayvees is the first new brand leveraging the Company’s patent-pending base material formulation.
LAS VEGAS and VANCOUVER, British Columbia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that in 2023 its subsidiary Beyond Alternatives LLC (“Beyond Alternatives”) will be pursuing additional applications of the Company’s proprietary base material in emerging market areas. In a press release dated December 22, 2022, the Company announced the Q4 2022 creation of Beyond Alternatives; an entity specializing in the development and commercialization of alternative products in growing categories.
The first brand to be brought to market by Beyond Alternatives is titled Jayvees, and will be launched at the CHAMPS trade show event in Las Vegas; taking place from Wednesday, February 8, 2023 through Saturday, February 11, 2023. More information about CHAMPS can be found on the parent organization’s website at the following link: https://champstradeshows.com/
The base material in Jayvees, which underwent years of development by TAAT® Founder Joe Deighan and Chief Science Officer Dr. Cindy Orser, has an advanced patent-pending formulation of reconstituted hemp. In addition to making for a smooth and stimulating smoking experience across a range of use cases for adult consumers, the proprietary formulation of the base material is conducive to an exceptionally high production velocity, allowing for favourable cost efficiency as well as a low barrier to upward scaling of production volume.
Jayvees Brand Overview
Beyond Alternatives’ inaugural brand Jayvees specializes in leveraging novel cannabinoids to provide unique experiences through combustible and edible products. Jayvees will initially offer four smokable varieties (Blue Dream, Menthol, OG Kush, and Tropical), sold in packs of ten sticks referred to as “Jays”. Additionally, Jayvees will offer four CBD-balanced varieties of edible chocolates (Milk Chocolate, Dark Chocolate, Cookies & Cream, and Peanut Butter).
Beyond Alternatives will commercialize Jayvees through the Company’s existing wholesale distribution infrastructure within the United States, anchored in Las Vegas, Nevada. Additionally, the Company’s Ohio-based subsidiary ADCO Distributors, Inc. (“ADCO”) placed its initial order of Jayvees in January 2023, and will carry Jayvees among its existing range of alternative and legacy products in the convenience category.
Jayvees will be the first brand launched under the Company’s subsidiary Beyond Alternatives. In addition to the four flavours of hemp “Jays” pictured above, Jayvees will offer four CBD-balanced varieties of edible chocolates.
Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media.
TAAT® Chief Executive Officer Michael Saxon commented, “We’re excited for what’s to come in 2023, as the CPG industry landscape continues to evolve. One of our objectives for this year is to fortify our market presence across multiple categories and geographies. There are many emerging segments where we believe the Company is favourably positioned to become an early entrant through Beyond Alternatives. Leveraging our ADCO distribution business will allow the product to get to market faster, and allow us to diversify our revenue streams. Jayvees will be Beyond Alternatives’ first brand to enter the market, and we are looking forward to launching its initial range of products at the CHAMPS trade show in Las Vegas.”
On behalf of the Board of Directors of the Company,
TAAT® GLOBAL ALTERNATIVES INC.
Michael Saxon, CEO and Director
For further information, please contact:
TAAT® Investor Relations1-833-TAAT-USA (1-833-822-8872)[email protected]
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.
About TAAT® Global Alternatives Inc.
TAAT® is a vertically integrated consumer product and distribution company, generating more than CAD $90 million in overall gross revenue annually. TAAT® is strategically expanding its product categories including tobacco and reduced-risk alternatives, hemp, kratom, and other emerging CPG segments. TAAT® has facilities to include a processing plant in Nevada as well as a distribution centre in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels.
For more information, please visit http://taatglobal.com.
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the anticipated performance of TAAT® in the tobacco industry, in addition to the following: Occurrence of the CHAMPS trade show event with Beyond Alternatives as an exhibitor, potential performance of Beyond Alternatives’ products. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets; (iii) changes to the regulatory landscape applicable to the Company's business; and (iv) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.
This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.
Statement Regarding Third-Party Investor Relations Firms
Disclosures relating to investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the Company's profile on http://sedar.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/aa0410e0-9c1d-42c2-af5a-2bb91eeb8ffc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bigbank’s Financial Results for November 2023
- FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease (CRSP) (VRTX) (BLUE)
- Posifa Technologies Introduces New MEMS Thermal Conductivity Sensors for A2L Refrigerant Leaks
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!